Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-22T19:55:35.033Z Has data issue: false hasContentIssue false

9 - Effect of hormones and hormonal treatment on cognition

Published online by Cambridge University Press:  13 August 2009

Christina A. Meyers
Affiliation:
University of Texas, M. D. Anderson Cancer Center
James R. Perry
Affiliation:
University of Toronto
Get access

Summary

Introduction

This chapter will address the possible influences of hormonal therapy on cognitive functioning. Hormonal therapy is an important treatment option for, among others, breast and prostate cancer. While there is increasing evidence that chemotherapy induces cognitive dysfunction in a subgroup of patients (Tannock et al., 2004), the effects of hormonal therapy on cognitive functioning have not been investigated thoroughly. Actually, it is conceivable that hormonal therapy also influences cognitive performance. After all, hormonal therapies interfere with serum levels of reproductive hormones (particularly estrogens and androgens) or with hormonal actions. There are indications that reproductive hormones are important in cognitive functioning (Bender et al., 2001). The mechanisms of action of reproductive hormones on brain structures are not entirely understood. One of the possibilities is that these hormones act through estrogen and androgen receptors that are present in those brain structures important for cognitive function, for example the hippocampi and the cerebral cortex (Norbury et al., 2003). Furthermore, it has been suggested that reproductive hormones have a beneficial effect on neurotransmitters that are involved in cognitive processes (Cholerton et al., 2002; Norbury et al., 2003).

Hormonal therapy is increasingly used for breast and prostate cancer, often for long periods and by elderly patients. Because intact cognitive functioning is essential for independent living and activities of daily life, elucidation of the possible effects of the various hormonal agents and treatment regimens is becoming increasingly important.

Type
Chapter
Information
Cognition and Cancer , pp. 115 - 141
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Almeida, OP, Waterreus, A, Spry, Net al. (2004). One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 29: 1071–1081.CrossRefGoogle ScholarPubMed
Azad, N, Pitale, S, Barnes, WEet al. (2003). Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab 88: 3064–3068.CrossRefGoogle ScholarPubMed
Barrett-Connor, E, Kritz-Silverstein, D (1993). Estrogen replacement therapy and cognitive function in older women. J Am Med Assoc 269: 2637–2641.CrossRefGoogle ScholarPubMed
Beer, TM, Bland, LB, Bussiere, JRet al. (2006). Testosterone loss and estradiol administration modify memory in men. J Urol 175: 130–135.CrossRefGoogle ScholarPubMed
Bender, CM, Paraska, KK, Sereika, SMet al. (2001). Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review. J Pain Symptom Manag 21: 407–424.CrossRefGoogle ScholarPubMed
Benson, JR (2002). Re: The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst 94: 1336–1337.CrossRefGoogle ScholarPubMed
Bowen, RL, Martins, RN, Gregory, CWet al. (2005). Dementia and testosterone levels in men. J Am Med Assoc 293: 551.Google ScholarPubMed
Chen, D, Wu, CF, Shi, Bet al. (2002a). Tamoxifen and toremifene cause impairment of learning and memory function in mice. Pharmacol Biochem Behav 71: 269–276.CrossRefGoogle ScholarPubMed
Chen, D, Wu, CF, Shi, Bet al. (2002b). Tamoxifen and toremifene impair retrieval, but not acquisition, of spatial information processing in mice. Pharmacol Biochem Behav 72: 417–421.CrossRefGoogle Scholar
Cherrier, MM, Asthana, S, Plymate, Set al. (2001). Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 57: 80–88.CrossRefGoogle ScholarPubMed
Cherrier, MM, Rose, AL, Higano, C (2003). The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 170: 1808– 1811.CrossRefGoogle ScholarPubMed
Cholerton, B, Gleason, CE, Baker, LDet al. (2002). Estrogen and Alzheimer's disease: the story so far. Drugs Aging 19: 405–427.CrossRefGoogle ScholarPubMed
Cook, IA, Morgan, ML, Dunkin, JJet al. (2002). Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry 17: 610– 618.CrossRefGoogle ScholarPubMed
Drake, EB, Henderson, VW, Stanczyk, FZet al. (2000). Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 54: 599–603.CrossRefGoogle ScholarPubMed
Eberling, JL, Reed, BR, Coleman, JEet al. (2000). Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology 55: 875–877.CrossRefGoogle ScholarPubMed
Eberling, JL, Wu, C, Tong-Turnbeaugh, Ret al. (2004). Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 21: 364–371.CrossRefGoogle ScholarPubMed
Ernst, T, Chang, L, Cooray, Det al. (2002). The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst 94: 592–597.CrossRefGoogle ScholarPubMed
Espeland, MA, Rapp, , Shumaker, SAet al. (2004). Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. J Am Med Assoc 291: 2959–2968.CrossRefGoogle ScholarPubMed
Fonda, SJ, Bertrand, R, O'Donnell, Aet al. (2005). Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci 60: 385–390.CrossRefGoogle ScholarPubMed
Ganz, PA, Castellon, SA, Silverman, DH (2002). Estrogen, tamoxifen, and the brain. J Natl Cancer Inst 94: 547–549.CrossRefGoogle Scholar
Gleason, CE, Cholerton, B, Carlsson, CMet al. (2005). Neuroprotective effects of female sex steroids in humans: current controversies and future directions. Cell Mol Life Sci 62: 299–312.CrossRefGoogle ScholarPubMed
Goss, PE, Strasser, K (2001). Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol 19: 881–894.CrossRefGoogle ScholarPubMed
Green, HJ, Pakenham, KI, Gardiner, RA (2000). Effects of luteinizing hormone releasing hormone analogs on cognition in women and men: a review. Psychol Health Med 5: 407–418.CrossRefGoogle Scholar
Green, HJ, Pakenham, KI, Headley, BCet al. (2002). Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 90: 427–432.CrossRefGoogle ScholarPubMed
Hampson, E (1990). Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn 14: 26–43.CrossRefGoogle ScholarPubMed
Haren, MT, Wittert, GA, Chapman, IMet al. (2005). Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas 50: 124–133.CrossRefGoogle ScholarPubMed
Hausmann, M, Slabbekoorn, D, Goozen, SHet al. (2000). Sex hormones affect spatial abilities during the menstrual cycle. Behav Neurosci 114: 1245–1250.CrossRefGoogle ScholarPubMed
Hellerstedt, BA, Pienta, KJ (2002). The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52: 154–179.CrossRefGoogle ScholarPubMed
Henderson, VW, Guthrie, JR, Dudley, ECet al. (2003). Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60: 1369–1371.CrossRefGoogle Scholar
Herr, HW, O'Sullivan, M (2000). Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol 163: 1743–1746.CrossRefGoogle ScholarPubMed
Hogervorst, E, Williams, J, Budge, Met al. (2001). Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol Lett 22: 163–168.Google ScholarPubMed
Hogervorst, E, Jager, C, Budge, Met al. (2004). Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology 29: 405–421.CrossRefGoogle ScholarPubMed
Janowsky, JS, Chavez, B, Orwoll, E (2000). Sex steroids modify working memory. J Cogn Neurosci 12: 407–414.CrossRefGoogle ScholarPubMed
Jenkins, VA, Bloomfield, DJ, Shilling, VMet al. (2005). Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 96: 48–53.CrossRefGoogle ScholarPubMed
Juul, A, Skakkebaek, NE (2002). Androgens and the ageing male. Hum Reprod Update 8: 423–433.CrossRefGoogle ScholarPubMed
Kenny, AM, Bellantonio, S, Gruman, CAet al. (2002). Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 57: M321–M325.Google ScholarPubMed
Luoto, R, Manolio, T, Meilahn, Eet al. (2000). Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study. J Am Geriatr Soc 48: 467–472.CrossRefGoogle ScholarPubMed
Maki, PM (2004). Hormone therapy and risk for dementia: where do we go from here?Gynecol Endocrinol 19: 354–359.CrossRefGoogle Scholar
Maki, PM, Resnick, SM (2000). Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21: 373–383.CrossRefGoogle ScholarPubMed
Maki, PM, Rich, JB, Rosenbaum, RS (2002). Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia 40: 518–529.CrossRefGoogle ScholarPubMed
Meyer, PM, Powell, LH, Wilson, RSet al. (2003). A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology 61: 801–806.CrossRefGoogle ScholarPubMed
Miller, WR (1996). Estrogens and Endocrine Therapy for Breast Cancer. Estrogen and Breast Cancer. Heidelberg: Springer Verlag.Google Scholar
Moffat, SD, Zonderman, AB, Metter, EJet al. (2004). Free testosterone and risk for Alzheimer disease in older men. Neurology 62: 188–193.CrossRefGoogle ScholarPubMed
Muller, M, Aleman, A, Grobbee, et al. (2005). Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level?Neurology 64: 866–871.CrossRefGoogle ScholarPubMed
Newton, C, Slota, D, Yuzpe, AAet al. (1996). Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertil Steril 65: 1253–1255.CrossRefGoogle ScholarPubMed
Nickelsen, T, Lufkin, EG, Riggs, BLet al. (1999). Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 24: 115–128.CrossRefGoogle ScholarPubMed
Norbury, R, Cutter, WJ, Compton, Jet al. (2003). The neuroprotective effects of estrogen on the aging brain. Exp Gerontol 38: 109–117.CrossRefGoogle ScholarPubMed
Nystedt, M, Berglund, G, Bolund, Cet al. (2000). Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer – self-rated physiological effects and symptoms. Acta Oncol 39: 959–968.Google ScholarPubMed
O'Connor, DB, Archer, J, Hair, WMet al. (2001). Activational effects of testosterone on cognitive function in men. Neuropsychologia 39: 1385–1394.CrossRefGoogle ScholarPubMed
Osborne, CK, Zhao, H, Fuqua, SA (2000). Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol 18: 3172–3186.CrossRefGoogle ScholarPubMed
Owens, JF, Matthews, KA, Everson, SA (2002). Cognitive function effects of suppressing ovarian hormones in young women. Menopause 9: 227–235.CrossRefGoogle ScholarPubMed
Paganini-Hill, A, Clark, LJ (2000). Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64: 165–176.CrossRefGoogle ScholarPubMed
Phillips, SM, Sherwin, BB (1992). Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17: 485–495.CrossRefGoogle ScholarPubMed
Rapp, , Espeland, MA, Shumaker, SAet al. (2003). Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J Am Med Assoc 289: 2663–2672.CrossRefGoogle ScholarPubMed
Resnick, SM, Maki, PM, Golski, Set al. (1998). Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 34: 171–182.CrossRefGoogle ScholarPubMed
Rosario, ER, Chang, L, Stanczyk, FZet al. (2004). Age-related testosterone depletion and the development of Alzheimer disease. J Am Med Assoc 292: 1431–1432.CrossRefGoogle ScholarPubMed
Salminen, E, Portin, R, Korpela, Jet al. (2003). Androgen deprivation and cognition in prostate cancer. Br J Cancer 89: 971–976.CrossRefGoogle ScholarPubMed
Salminen, EK, Portin, RI, Koskinen, Aet al. (2004). Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res 10: 7575–7582.CrossRefGoogle ScholarPubMed
Salminen, EK, Portin, RI, Koskinen, AIet al. (2005). Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer 103: 1381–1387.CrossRefGoogle ScholarPubMed
Sanders, G, Sjodin, M, Chastelaine, M (2002). On the elusive nature of sex differences in cognition: hormonal influences contributing to within-sex variation. Arch Sex Behav 31: 145–152.CrossRefGoogle ScholarPubMed
Schagen, SB (2002). Cognitive function following chemotherapy: a study in breast cancer patients. Ph.D Thesis. University of Amsterdam.Google ScholarPubMed
Schmidt, R, Fazekas, F, Reinhart, Bet al. (1996). Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc 44: 1307–1313.CrossRefGoogle ScholarPubMed
Sharifi, N, Gulley, JL, Dahut, WL (2005). Androgen deprivation therapy for prostate cancer. J Am Med Assoc 294: 238–244.CrossRefGoogle ScholarPubMed
Shaywitz, SE, Shaywitz, BA, Pugh, KRet al. (1999). Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. J Am Med Assoc 281: 1197–1202.CrossRefGoogle ScholarPubMed
Sherwin, BB (1988). Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13: 345–357.CrossRefGoogle ScholarPubMed
Sherwin, BB (2000). Oestrogen and cognitive function throughout the female lifespan. Novartis Found Symp 230: 188–196.Google ScholarPubMed
Sherwin, BB (2003). Steroid hormones and cognitive functioning in aging men: a mini-review. J Mol Neurosci 20: 385–393.CrossRefGoogle ScholarPubMed
Sherwin, BB (2005). Estrogen and memory in women: how can we reconcile the findings?Horm Behav 47: 371–375.CrossRefGoogle ScholarPubMed
Sherwin, BB, Tulandi, T (1996). “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81: 2545–2549.Google ScholarPubMed
Shilling, V, Jenkins, V, Fallowfield, Let al. (2003). The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol 86: 405–412.CrossRefGoogle ScholarPubMed
Shumaker, SA, Legault, C, Rapp, SRet al. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J Am Med Assoc 289: 2651–2662.CrossRefGoogle ScholarPubMed
Shumaker, SA, Legault, C, Kuller, Let al. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. J Am Med Assoc 291: 2947–2958.CrossRefGoogle ScholarPubMed
Simpson, ER, Dowsett, M (2002). Aromatase and its inhibitors: significance for breast cancer therapy. Recent Prog Horm Res 57: 317–338.CrossRefGoogle ScholarPubMed
Tannock, IF, Ahles, TA, Ganz, PAet al. (2004). Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22: 2233–2239.CrossRefGoogle ScholarPubMed
Taxel, P, Stevens, MC, Trahiotis, Met al. (2004). The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. J Am Geriatr Soc 52: 269– 273.CrossRefGoogle ScholarPubMed
Tripathy, D, Benz, CC (2001). Hormones and cancer. In FS, Greenspan, DG, Gardner (eds.) Basic and Clinical Endocrinology. New York: Lange Medical Books.Google Scholar
Verghese, J, Kuslansky, G, Katz, MJet al. (2000). Cognitive performance in surgically menopausal women on estrogen. Neurology 55: 872–874.CrossRefGoogle ScholarPubMed
Visvanathan, K, Davidson, NE (2003). Aromatase inhibitors as adjuvant therapy in breast cancer. Oncology (Huntingt) 17: 335–342, 347.Google ScholarPubMed
Wolf, OT, Kirschbaum, C (2002). Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav 41: 259–266.CrossRefGoogle ScholarPubMed
Wolf, OT, Neumann, O, Hellhammer, DHet al. (1997). Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 82: 2363–2367.Google ScholarPubMed
Yaffe, K, Sawaya, G, Lieberburg, Iet al. (1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J Am Med Assoc 279: 688–695.CrossRefGoogle ScholarPubMed
Yaffe, K, Krueger, K, Sarkar, Set al. (2001). Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 344: 1207–1213.CrossRefGoogle ScholarPubMed
Yaffe, K, Lui, LY, Zmuda, Jet al. (2002). Sex hormones and cognitive function in older men. J Am Geriatr Soc 50: 707–712.CrossRefGoogle ScholarPubMed
Yaffe, K, Krueger, K, Cummings, SRet al. (2005). Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 162: 683–690.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×